Report overview
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
This report aims to provide a comprehensive presentation of the global market for Injectable Implant Urinary Incontinence Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Implant Urinary Incontinence Device. This report contains market size and forecasts of Injectable Implant Urinary Incontinence Device in global, including the following market information:
Global Injectable Implant Urinary Incontinence Device Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Injectable Implant Urinary Incontinence Device Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Injectable Implant Urinary Incontinence Device companies in 2022 (%)
The global Injectable Implant Urinary Incontinence Device market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Stress Incontinence Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injectable Implant Urinary Incontinence Device include Boston Scientific, Laborie Medical and Urogyn B.V., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Implant Urinary Incontinence Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Implant Urinary Incontinence Device Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Implant Urinary Incontinence Device Market Segment Percentages, by Type, 2022 (%)
Stress Incontinence
Urge Incontinence
Overflow Incontinence
Functional Incontinence
Others
Global Injectable Implant Urinary Incontinence Device Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Implant Urinary Incontinence Device Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Ambulatory Surgery Centres
Others
Global Injectable Implant Urinary Incontinence Device Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Injectable Implant Urinary Incontinence Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Implant Urinary Incontinence Device revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Injectable Implant Urinary Incontinence Device revenues share in global market, 2022 (%)
Key companies Injectable Implant Urinary Incontinence Device sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Injectable Implant Urinary Incontinence Device sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Laborie Medical
Urogyn B.V.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Implant Urinary Incontinence Device, market overview.
Chapter 2: Global Injectable Implant Urinary Incontinence Device market size in revenue and volume.
Chapter 3: Detailed analysis of Injectable Implant Urinary Incontinence Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Implant Urinary Incontinence Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Injectable Implant Urinary Incontinence Device capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
